Drugmakers Get Blowback As 340B Changes Gain Steam
Republican-led efforts to increase hospital transparency in the 340B drug discount program encountered turbulence on Capitol Hill on Thursday as Democrats spotlighted secrecy surrounding drugmaker pricing practices....To view the full article, register now.
Already a subscriber? Click here to view full article